New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
Fulltekst
RELATERTE DOKUMENTER
A method for direct monitoring of atorvastatin adherence in cardiovascular disease prevention: Quantification of the total exposure to parent drug and major metabolites
11 Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection
Coronary heart disease, lifestyle, secondary prevention, risk factors, psychosocial factors, long- 44.. term follow-up
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.. Shepherd J, Cobbe SM, Ford I
ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.. Downs JR, Clearfield M, Weis
He has chaired the 2009 revision of Norwegian Guidelines for Primary Prevention of Cardiovascular Disease, the World Health Organization ’ s Consultative Group on Equity and
Abbreviations: ACC = American College of Cardiology, ACE = angiotensin-converting-enzyme, AHA = American Heart Association, ARB = Angiotensin II Receptor Blockers, BMI = body
